DUX4 and Facioscapulohumeral dystrophy: This work also provides reliable readouts for monitoring FSHD muscle function, including those that might be secondary or downstream of DUX4, opening new grounds for the identification of therapeutic targets able to correct the typical muscle weakening that precedes muscle atrophy and fatigue.